NCT06786533
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- MD Anderson Houston, Texas, United States
Clinical trial condition
Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
Explore clinical trials studying Relapsed/Refractory Acute Myeloid Leukemia (R/R AML). Study availability and eligibility vary by location and protocol.
2 public trials
2 recruiting studies
Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) trial results
NCT05924750
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Anhui Provincial Hospital Hefei, Anhui, China
- Beijing Hospital Beijing, Beijing Municipality, China
- Institute of Hematology, the First Hospital of Harbin Haerbin, Heilongjiang, China
- Shengjing Hospital of China Medical University Shenyang, Liaoning, China